Proteolipidic vectors for gene transfer to the lung

Biochemical and Biophysical Research Communications

Volumn 290, Issue 5, 2002, Pages 1489-1498

  Vaysse, Laurence ^a   Burgelin, Ingrid ^a   Arveiler, Benot ^a   Guillaume, Christine ^b   Férec, Claude ^b   Gorry, Philippe ^c  

^a UNIVERSITÉ DE BORDEAUX   (France)

^b Ctr Transfus Sang de Biogenetique   (France)

^c INSTITUT BERGONIÉ   (France)

Author keywords

Cationic lipid; DNA binding peptide; Gene transfer; Ligand; Lung; Phage display; Synthetic vectors

Indexed keywords

DNA BINDING PROTEIN; LIPID; LUCIFERASE;

AEROSOL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DNA TRANSFECTION; GENE TRANSFER; IN VIVO STUDY; LUNG PARENCHYMA; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; REPORTER GENE;

EID: 0036297624     PISSN: 0006291X     EISSN: None     Source Type: Journal    
DOI: 10.1006/bbrc.2002.6343     Document Type: Article

References (50)

1. Adenovirus-mediated gene transfer transiently corrects the chloride transport defect in nasal epithelia of patients with cystic fibrosis
2. Gene therapy for cystic fibrosis using E1-deleted adenovirus: A phase I trial in the nasal cavity
3. Modification of nasal epithelial potential differences of individuals with cystic fibrosis consequent to local administration of a normal CFTR cDNA adenovirus gene transfer vector
4. A controlled study of adenoviral-vector-mediated gene transfer in the nasal epithelium of patients with cystic fibrosis
5. Aerosol administration of a recombinant adenovirus expressing CFTR to cystic fibrosis patients: A phase I clinical trial
6. Administration of an adenovirus containing the human CFTR cDNA to the respiratory tract of individuals with cystic fibrosis
7. Repeat administration of an adenovirus vector encoding cystic fibrosis transmembrane conductance regulator to the nasal epithelium of patients with cystic fibrosis
8. Airway epithelial CFTR mRNA expression in cystic fibrosis patients after repetitive administration of a recombinant adenovirus
9. Laboratory and clinical studies in support of cystic fibrosis gene therapy using pCMV-CFTR-DOTAP
10. In vivo gene transfer via intravenous administration of cationic lipid-protamine-DNA (LPD) complexes
11. Liposome-mediated CFTR gene transfer to the nasal epithelium of patients with cystic fibrosis
12. Safety of a single aerosol administration of escalating doses of the cationic lipid GL-67/DOPE/DMPE-PEG5000 formulation to the lungs of normal volunteers
13. A placebo-controlled study of liposome-mediated gene transfer to the nasal epithelium of patients with cystic fibrosis
14. Evidence for safety and efficacy of DOTAP cationic liposome mediated CFTR gene transfer to the nasal epithelium of patients with cystic fibrosis
15. Repeat nasal administration of liposome-mediated CFTR gene transfer reagents: The clinical and immunological consequences
16. Cationic lipid-mediated CFTR gene transfer to the lungs and nose of patients with cystic fibrosis double-blind placebo-controlled trial
17. Potentiation of cationic liposome-mediated gene delivery by polycations
18. Gene transfer into mammalian cells using histone-condensed plasmid DNA
19. Condensation of plasmid DNA with polylysine improves liposome-mediated gene transfer into established and primary muscle cells
20. Synthetic DNA compacting petides derived from human sequences enhance cationic lipid-mediated gene transfer in vitro and in vivo
21. Evidence for targeted gene delivery to Hep G2 Hepatoma cells in vitro
22. Specific gene transfer mediated by lactosylated poly-L-lysine into hepatoma cells
23. Biochemical and functional characterization of DNA complexes capable of targeting genes to hepatocytes via the asialoglycoprotein receptor
24. Hepatocyte-targeted in vivo gene expression by intravenous injection of plasmid DNA complexed with synthetic multi-functional gene delivery system
25. Sugar-mediated uptake of a glycosylated polylysines and gene transfer into normal and cystic fibrosis airway epithelial cells
26. High-efficiency transfer of cystic fibrosis transmembrane conductance regulator CDNA into cystic fibrosis airway cells in culture using lactosylated polylysine as a vector
27. Liposomes enhance delivery and expression of an RGD-oligolysine gene transfer vector in human tracheal cells
28. An integrin-targeted non-viral vector for pulmonary gene therapy
29. Comparison between intratracheal and intravenous administration of liposome-DNA complexes for cystic fibrosis lung gene therapy
30. Systemic gene expression after intravenous DNA delivery into adult mice
31. Systemic gene therapy: Biodistribution and long-term expression of a transgene in mice
32. Systemic linear polyethylenimine (L-PEI)-mediated gene delivery in the mouse
33. Polyethylenimine-based intravenous delivery of transgenes to mouse lung
34. Comparison between cationic polymers and lipids in mediating systemic gene delivery to the lungs
35. Transfection using synthetic peptides: Comparison of three DNA-compacting peptides, and effect of centrifugation
36. Improved transfection using epithelial cell line-selected ligands and fusogenic peptides
37. A human pancreatic secretory trypsin inhibitor presenting a hypervariable highly constrained epitope via monovalent phagemid display
38. Peptides on phage: A vast library of peptides for identifying ligands
39. Libraries of peptides and proteins displayed on filamentous phage
40. A concentrated and stable aerosol formulation of cationic lipid: DNA complexes giving high-level gene expression in mouse lung
41. Systemic administration of cationic phosphonolipids/DNA complexes and the relationship between formulation and lung transfection efficiency
42. Cationic phosphonolipids as nonviral gene transfer agents in the lungs of mice
43. Lipoplex-mediated gene delivery to the lung occurs within 60 minutes of intravenous administration
44. Characterization of cationic liposome-mediated gene transfer in vivo by intravenous administration
45. Lipospermine-based gene transfer into the newborn mouse brain is optimized by a low lipospermine/DNA charge ratio
46. A novel series of amphiphilic imidazolinium compounds for in vitro and in vivo gene delivery
47. Integrin-mediated transfection with peptides containing arginine-glycine-aspartic acid domains
48. An RGD-oligolysine peptide: A prototype construct for integrin-mediated gene delivery
49. Submucosal glands are the predominant site of CFTR expression in the human bronchus
50. Cellular heterogeneity of CFTR expression and function in the lung: Implications for gene therapy of cystic fibrosis